This session will highlight recent research studying assessment and treatment of the gastrointestinal and liver manifestations of cystic fibrosis. The session will focus on: 1) assessment of common CF gastrointestinal problems, including development of innovative therapies; and 2) clinical research to better understand manifestations of and outcomes for CF-related liver disease.
Recall the definition of CF-related liver disease and appraise the associations of CF-related liver disease with insulin resistance and mortality.
Examine methods for novel drug development and application in constipation in CF.
Assess esophageal impedance and gut microbiota dysbiosis in pediatric patients with CF.